Ergotamine will increase the level or impact of finerenone by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Keep track of Closely. Keep track of serum potassium during initiation and dosage adjustment of possibly finererone or weak CYP3A4 inhibitors. Alter finererone dosage as wanted. Mainly because CYP3A4 inhibition elevates ergotamine and caffeine https://remingtonzrena.gynoblog.com/28824551/examine-this-report-on-cafergot-discontinued